ADH-1 trifluoroacetate

ADH-1 trifluoroacetate is a synthetic cyclic pentapeptide characterized by the amino acid sequence N-Ac-Cys-Asp-Pro-His-Phe-NH2, commonly recognized for its potent antagonistic activity against N-cadherin-mediated cell adhesion. As a peptide compound, it is widely utilized in biochemical and cell biology research to dissect cellular adhesion mechanisms, offering a valuable tool for studies into cell-cell interaction, tissue morphogenesis, and signal transduction. The trifluoroacetate salt form enhances its solubility and stability, making it suitable for a range of in vitro experimental applications. Researchers leverage ADH-1 to probe the functional significance of N-cadherin in both normal and pathological contexts, particularly where cell adhesion dynamics are central to the investigation.

Cell Adhesion Studies: ADH-1 trifluoroacetate serves as a powerful molecular probe for investigating the role of N-cadherin in mediating cell-cell adhesion. By competitively inhibiting N-cadherin interactions, it enables researchers to selectively disrupt cadherin-dependent junctions in cultured cells, facilitating the analysis of downstream effects on cellular morphology, migration, and signaling pathways. Such studies are critical for elucidating the molecular underpinnings of tissue architecture, embryonic development, and cellular communication.

Signal Transduction Research: The peptide's ability to modulate N-cadherin function makes it instrumental in exploring signal transduction pathways that are regulated by cell adhesion events. Disruption of N-cadherin-mediated contacts using ADH-1 can reveal how extracellular adhesion cues are transduced into intracellular signaling cascades, influencing processes such as cell proliferation, differentiation, and survival. This application is particularly relevant in understanding the cross-talk between adhesion molecules and growth factor receptors.

Cancer Biology Investigations: In the context of tumor biology, ADH-1 trifluoroacetate is frequently employed to interrogate the involvement of N-cadherin in cancer cell invasion, metastasis, and epithelial-mesenchymal transition (EMT). By selectively blocking N-cadherin function, researchers can assess its contribution to tumor progression, metastatic dissemination, and cellular plasticity. These insights are pivotal for identifying molecular targets and mechanisms underlying malignancy.

Peptide Functional Analysis: The compound is also utilized in the broader field of peptide research to examine structure-activity relationships of cyclic peptides and their interactions with cellular proteins. Studies employing ADH-1 provide valuable data on the conformational requirements for N-cadherin antagonism, informing the design of novel peptide-based modulators and advancing understanding of peptide-protein recognition principles.

In vitro Assay Development: ADH-1 trifluoroacetate is incorporated into various biochemical and cell-based assay systems as a reference inhibitor or functional control for N-cadherin activity. Its well-characterized mechanism of action allows for the establishment of robust experimental models to screen for new adhesion modulators, validate assay specificity, or benchmark the efficacy of candidate compounds targeting cadherin-mediated processes. Such applications support the advancement of research tools and methodologies in cell adhesion biology.

1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)